Quality Control & Analytics

Our highly qualified quality team is closely integrated into all manufacturing processes. A Quality Shop Floor Team supports production on-site with hands-on experience and supervision of critical process steps. Close cooperation of quality experts with manufacturing and engineering activities is key to a reliable supply of high-quality vaccines and pharmaceuticals. Therefore, experts leading root cause investigations and maintaining Quality Oversight are located within manufacturing buildings. This makes internal communication and exchanges with clients very fast and to-the-point.

IDT Biologika’s Quality Oversight system is based on the constant monitoring of all relevant GMP guidelines. New developments are integrated into the Quality Systems of IDT Biologika to keep all manufacturing activities compliant with regulatory requirements. Transparent collaboration with clients is a key aspect in ensuring compliance to regulatory filings as well.

Quality Risk Management forms an integral part of the Quality System and is deeply ingrained in the internal quality processes. A professional Audit Management Team takes care of all client audits and authority inspections to provide the best possible presentation of IDT Biologika. The approach to quality is universal but fully considers different regulatory requirements. IDT Biologika supports product release by Qualified Persons (QP) in Europe and Quality Assurance release in the U.S.

Our Quality Control and Analytical Development Teams support a wide array of analytical technologies needed to develop novel assays for the characterization, release, and stability testing of early-phase vaccines, gene therapy vectors, and protein therapeutics.

An electronic sample management system, which is integrated into internal logistics, keeps track of all samples taken and provides temperature-controlled delivery to quality control laboratories. Quality control supervises all sampling activities for incoming goods, in-process controls, and product release. This includes AQL testing in visual inspection.

In IDT Biologika’s laboratories, a comprehensive spectrum of validated analytical methods for biological, microbiological, physico-chemical, and molecular biology methods is maintained on state-of-the-art equipment. These enable us to conduct all the testing required by contract manufacturing clients’ processes according to EP, USP and JP. Our team has experience with approximately 1,500 internal methods. For very specialized methods, a network of several qualified contract control laboratories supports IDT Biologika where necessary.

De novo method development in early-phase projects is a core competency of the Analytical Development Team at IDT Biologika. Growth of analytical and process knowledge over the product lifecycle is reflected in the individual method development plans to ensure the appropriate level of method qualification and validation from early toxicology material.

In cooperation with our Analytical Development Group, we provide continuous development of innovative analytical methods such as qPCR/dPCR, next-generation sequencing (NGS), fluorescence-activated cell sorting (FACS) analysis, lighthouse analytics, and virus-based titration assays. We offer in-depth expertise in analytical method development, method transfer, optimization, verification and validation.